About us
Our Mission
The ATTC Network is dedicated to establishing robust systems for the routine delivery of ATMPs throughout the NHS in the United Kingdom. Central to its mission is the acceleration of ATMP clinical trials, leveraging and building on existing expertise and resources.
Cell and gene therapies continue to be developed to treat some cancers and degenerative, genetic and immune disorders. These advanced therapies are different from existing treatments in two important ways: they are designed to restore normal function, potentially offering cures where an unmet medical need exists and they require new ways of working by the NHS.
The ATTC network was established in 2018 with funding through the UKRI Medicines Manufacturing Challenge, delivered by Innovate UK. The network is a UK wide group of Advanced Therapy Treatment Centres (ATTC) operating within the NHS framework and coordinated by the Cell and Gene Therapy Catapult (CGT Catapult) to address the unique and complex challenges of bringing pioneering advanced therapy medicinal products (ATMPs) to patients. The centres are:
• Innovate Manchester Advanced Therapy Centre Hub (iMATCH),
• Midlands-Wales Advanced Therapy Treatment Centre (MW-ATTC) and
• Northern Alliance Advanced Therapies Treatment Centre (NA-ATTC)
Since establishment, the network has developed and shared a body of knowledge and practice that has allowed and facilitated the NHS to deliver advanced therapies.
Through further funding provided by the National Institute for Health and Care Research (NIHR), and working in close collaboration with NIHR’s research infrastructure and the devolved equivalents, the network aims to build on its work on advanced therapy clinical trial readiness to ensure the UK maintains its position as a globally attractive location for clinical research.
The CGT Catapult is playing a central coordination role for the Network and providing it with clinical trial and R&D support, as well as in manufacturing, supply chain logistics, regulatory affairs, and upskilling via specialist training and development.
Interested in learning more about Cell and Gene Therapy?
Watch this video from NIHR
CGT Catapult team
- Jacqueline Barry, Chief Clinical Officer
- Finn Willingham, Head of ATTC Network Coordination
- Kelsie Thomas, Network Programme Manager
- Dan Baston, Network Programme Manager
Looking for more information?
Find details of how to contact us here
Visit our centres
